Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01592071 · ClinicalTrials.gov registry record · NA

IgG-mediated Food Test for Weight Loss

A NA study of Overweight and Obesity, sponsored by University of Miami.

Completed
Registry status
NA
Development phase
120
Enrollment target
1
Study location

NCT01592071 is a NA study of Overweight and Obesity that has completed, run by University of Miami. The registered enrollment target is 120 participants, below the 227-participant average among 115 other Overweight and Obesity trials with a reported enrollment target (47% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01592071, a NA study of Overweight and Obesity, has completed, sponsored by University of Miami.

COMPLETED
Registry status
NA
Development phase
120 participants
Enrollment target
1
Study location

Study Summary

This study assessed the effect of an IgG-mediated food sensitivity test in combination with a food elimination diet on body composition and secondary outcomes in people who were overweight.

Conditions Studied

Overweight and Obesity

Interventions

  • OTHER Replace reactive foods with non-reactive foods

Study Locations (1)

Florida

  • University of Miami CRB - Miami

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2008-10
Est. Completion 2010-10
Phase NA

Sponsor

University of Miami

721 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01592071

The ClinicalTrials.gov registry entry for NCT01592071 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 227-participant average among 115 other Overweight and Obesity trials with a reported enrollment target (47% lower). The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Overweight and Obesity appearing as the primary indexed condition, and to 1 intervention - of which Replace reactive foods with non-reactive foods is the first listed.

NCT01592071 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT01592071 about?

NCT01592071 is a clinical study titled "IgG-mediated Food Test for Weight Loss". This study assessed the effect of an IgG-mediated food sensitivity test in combination with a food elimination diet on body composition and secondary outcomes in people who were overweight.

What is the current status of trial NCT01592071?

This trial is currently completed. It is a NA study. The enrollment target is 120 participants. The study started on 2008-10. Estimated completion is 2010-10.

What conditions does trial NCT01592071 study?

This clinical trial studies the following conditions: Overweight and Obesity.

What interventions are being tested in trial NCT01592071?

The interventions under investigation include: Replace reactive foods with non-reactive foods (OTHER).

Who is sponsoring clinical trial NCT01592071?

This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01592071 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Overweight and Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Overweight and Obesity

All registered trials for this condition

Florida

All trials with a study site in Florida

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.